Hyperactive mTOR signaling has been implicated in many age-related conditions–cancer, type 2 diabetes, neurodegeneration–and in the aging process itself (Johnson et al., 2013; López-Otín et al., 2013; Longo et al., 2015; Saxton and Sabatini, 2017). Here, MTOR is linked to cancer.